134 related articles for article (PubMed ID: 34046926)
1. Antizyme inhibitor 2 (AZIN2) associates with better prognosis of head and neck minor salivary gland adenoid cystic carcinoma.
Hämetoja H; Andersson LC; Mäkitie A; Bäck L; Hagström J; Haglund C
APMIS; 2021 Aug; 129(8):503-511. PubMed ID: 34046926
[TBL] [Abstract][Full Text] [Related]
2. Ornithine decarboxylase antizyme inhibitor 2 (AZIN2) is a signature of secretory phenotype and independent predictor of adverse prognosis in colorectal cancer.
Kaprio T; Rasila T; Hagström J; Mustonen H; Lankila P; Haglund C; Andersson LC
PLoS One; 2019; 14(2):e0211564. PubMed ID: 30768610
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 5 and 7 expression in adenoid cystic carcinoma of major salivary glands.
Hirvonen K; Bäck L; Haglund C; Leivo I; Jouhi L; Mäkitie AA; Hagström J
Tumour Biol; 2016 Aug; 37(8):10959-64. PubMed ID: 26888781
[TBL] [Abstract][Full Text] [Related]
4. Ornithine decarboxylase antizyme inhibitor 2 regulates intracellular vesicle trafficking.
Kanerva K; Mäkitie LT; Bäck N; Andersson LC
Exp Cell Res; 2010 Jul; 316(11):1896-906. PubMed ID: 20188728
[TBL] [Abstract][Full Text] [Related]
5. Early stage minor salivary gland adenoid cystic carcinoma has favourable prognosis.
Hämetoja H; Hirvonen K; Hagström J; Leivo I; Saarilahti K; Apajalahti S; Haglund C; Mäkitie A; Bäck L
Virchows Arch; 2017 Dec; 471(6):785-792. PubMed ID: 28600602
[TBL] [Abstract][Full Text] [Related]
6. High expression of H3K9me3 is a strong predictor of poor survival in patients with salivary adenoid cystic carcinoma.
Xia R; Zhou R; Tian Z; Zhang C; Wang L; Hu Y; Han J; Li J
Arch Pathol Lab Med; 2013 Dec; 137(12):1761-9. PubMed ID: 24283856
[TBL] [Abstract][Full Text] [Related]
7. Developmental transcription factor EN1--a novel biomarker in human salivary gland adenoid cystic carcinoma.
Bell D; Bell A; Roberts D; Weber RS; El-Naggar AK
Cancer; 2012 Mar; 118(5):1288-92. PubMed ID: 21800291
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-7, -8, -9, -15, and -25 in minor salivary gland adenoid cystic carcinoma.
Hämetoja H; Mäkitie A; Bäck L; Leivo I; Haglund C; Sorsa T; Hagström J
Pathol Res Pract; 2021 Jan; 217():153293. PubMed ID: 33278774
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of expression of molecular markers in adenoid cystic cancer of the salivary glands compared with lymph node metastasis: a retrospective study.
Lee SK; Kwon MS; Lee YS; Choi SH; Kim SY; Cho KJ; Nam SY
World J Surg Oncol; 2012 Dec; 10():266. PubMed ID: 23231994
[TBL] [Abstract][Full Text] [Related]
10. Structural and degradative aspects of ornithine decarboxylase antizyme inhibitor 2.
Ramos-Molina B; Lambertos A; Lopez-Contreras AJ; Kasprzak JM; Czerwoniec A; Bujnicki JM; Cremades A; Peñafiel R
FEBS Open Bio; 2014; 4():510-21. PubMed ID: 24967154
[TBL] [Abstract][Full Text] [Related]
11. Glycoconjugate expression in adenoid cystic carcinoma of the salivary glands: up-regulation of L1 predicts fatal prognosis.
Dahl A; Teegen J; Altevogt P; Löning T; Schumacher U
Histopathology; 2011 Aug; 59(2):299-307. PubMed ID: 21884209
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of quantitative p63 immunostaining in adenoid cystic carcinoma of salivary gland assessed by computerized image analysis.
Ramer N; Wu H; Sabo E; Ramer Y; Emanuel P; Orta L; Burstein DE
Cancer; 2010 Jan; 116(1):77-83. PubMed ID: 19877114
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic implications of Myb and Beta-catenin expression in adenoid cystic carcinoma.
Park S; Vora M; van Zante A; Humtsoe J; Kim HS; Yom S; Agarwal S; Ha P
J Otolaryngol Head Neck Surg; 2020 Jul; 49(1):48. PubMed ID: 32650834
[TBL] [Abstract][Full Text] [Related]
14. Association between high expression of phosphorylated Akt and mammalian target of rapamycin and improved survival in salivary gland adenoid cystic carcinoma.
Ouyang DQ; Liang LZ; Ke ZF; Zheng GS; Weng DS; Yang WF; Su YX; Liao GQ
Head Neck; 2017 Jun; 39(6):1145-1154. PubMed ID: 28230926
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the demographics, clinical features, and survival of patients with adenoid cystic carcinoma of major and minor salivary glands versus less common sites within the Surveillance, Epidemiology, and End Results registry.
Li N; Xu L; Zhao H; El-Naggar AK; Sturgis EM
Cancer; 2012 Aug; 118(16):3945-53. PubMed ID: 22179977
[TBL] [Abstract][Full Text] [Related]
16. High expression of antizyme inhibitor 2, an activator of ornithine decarboxylase in steroidogenic cells of human gonads.
Mäkitie LT; Kanerva K; Sankila A; Andersson LC
Histochem Cell Biol; 2009 Dec; 132(6):633-8. PubMed ID: 19756694
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of p53 immunohistochemical expression in adenoid cystic carcinoma of the salivary glands: a meta-analysis.
Li Q; Huang P; Zheng C; Wang J; Ge M
Oncotarget; 2017 Apr; 8(17):29458-29473. PubMed ID: 28206977
[TBL] [Abstract][Full Text] [Related]
18. Expression of ODC Antizyme Inhibitor 2 (AZIN2) in Human Secretory Cells and Tissues.
Rasila T; Lehtonen A; Kanerva K; Mäkitie LT; Haglund C; Andersson LC
PLoS One; 2016; 11(3):e0151175. PubMed ID: 26963840
[TBL] [Abstract][Full Text] [Related]
19. Antizyme inhibitor 2: molecular, cellular and physiological aspects.
López-Contreras AJ; Ramos-Molina B; Cremades A; Peñafiel R
Amino Acids; 2010 Feb; 38(2):603-11. PubMed ID: 19956990
[TBL] [Abstract][Full Text] [Related]
20. Ataxia-Telangiectasia-Mutated Protein Expression as a Prognostic Marker in Adenoid Cystic Carcinoma of the Salivary Glands.
Bazarsad S; Kim JY; Zhang X; Kim KY; Lee DY; Ryu MH; Kim J
Yonsei Med J; 2018 Aug; 59(6):717-726. PubMed ID: 29978608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
